PLURISTEM THERAPEUTICS INC's ticker is and the CUSIP is 72940R902. A total of 2 filers reported holding PLURISTEM THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $66,000 | -64.9% | 106,600 | -55.4% | 0.00% | -50.0% |
| Q4 2018 | $188,000 | -40.9% | 239,000 | -2.4% | 0.00% | -33.3% |
| Q3 2018 | $318,000 | +68.3% | 244,900 | +57.7% | 0.00% | +50.0% |
| Q2 2018 | $189,000 | +7.4% | 155,300 | +20.7% | 0.00% | 0.0% |
| Q1 2018 | $176,000 | +15.0% | 128,700 | +16.1% | 0.00% | +100.0% |
| Q4 2017 | $153,000 | +56.1% | 110,900 | +71.1% | 0.00% | 0.0% |
| Q3 2017 | $98,000 | -60.5% | 64,800 | -66.5% | 0.00% | -66.7% |
| Q2 2017 | $248,000 | +439.1% | 193,500 | +418.8% | 0.00% | +200.0% |
| Q1 2017 | $46,000 | +15.0% | 37,300 | +32.3% | 0.00% | – |
| Q4 2016 | $40,000 | +166.7% | 28,200 | +151.8% | 0.00% | – |
| Q2 2016 | $15,000 | +66.7% | 11,200 | +107.4% | 0.00% | – |
| Q1 2016 | $9,000 | +50.0% | 5,400 | +8.0% | 0.00% | – |
| Q4 2015 | $6,000 | -50.0% | 5,000 | -21.9% | 0.00% | – |
| Q3 2015 | $12,000 | -95.0% | 6,400 | -93.3% | 0.00% | -100.0% |
| Q2 2015 | $240,000 | -0.4% | 95,100 | +10.5% | 0.00% | -25.0% |
| Q1 2015 | $241,000 | – | 86,100 | +86000.0% | 0.00% | – |
| Q2 2014 | $0 | -100.0% | 100 | -100.0% | 0.00% | -100.0% |
| Q1 2014 | $775,000 | +90.4% | 209,400 | +81.0% | 0.01% | +116.7% |
| Q4 2013 | $407,000 | +123.6% | 115,700 | +115.1% | 0.01% | +100.0% |
| Q3 2013 | $182,000 | -38.7% | 53,800 | -44.7% | 0.00% | -57.1% |
| Q2 2013 | $297,000 | – | 97,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|